Edward M. MD Kaye - CEO, Director at Stoke Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CEO, Director
Stock Symbol
STOK on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Edward M. MD Kaye - trading volume in the past year for Stoke Therapeutics, Inc.

Holdings reported by Edward M. MD Kaye for Stoke Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Restricted Stock Units 105K $1.66M $15.78 Mar 27, 2024 Direct Common Stock
Common Stock 27K $433K $16.05 May 20, 2024 Direct
Employee Stock Option (Right to Buy) 159K Mar 27, 2024 Direct Common Stock

Transactions reported by Edward M. MD Kaye for Stoke Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.